Technical specifications of the Global Allergy and Asthma European Network (GA2LEN) chamber: a novel mobile allergen exposure chamber

[1]  T. Zuberbier,et al.  Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future – an EAACI Position Paper , 2017, Allergy.

[2]  T. Zuberbier,et al.  Spatial distribution of allergenic pollen through a large metropolitan area , 2017, Environmental Monitoring and Assessment.

[3]  T. Zuberbier,et al.  Intradiurnal patterns of allergenic airborne pollen near a city motorway in Berlin, Germany , 2016, Aerobiologia.

[4]  R. Jacobs,et al.  Symptom dynamics during repeated serial allergen challenge chamber exposures to house dust mite. , 2015, The Journal of allergy and clinical immunology.

[5]  S. Vieths,et al.  Environmental exposure chambers in allergen immunotherapy trials: Current status and clinical validation needs. , 2015, The Journal of allergy and clinical immunology.

[6]  R. Jacobs,et al.  Effect of confounding cofactors on responses to pollens during natural season versus pollen challenge chamber exposure. , 2014, The Journal of allergy and clinical immunology.

[7]  K. Bergmann,et al.  Development of a symptom load index: enabling temporal and regional pollen season comparisons and pointing out the need for personalized pollen information , 2014, Aerobiologia.

[8]  Y. Okamoto,et al.  Characteristics of the Chiba environmental challenge chamber. , 2014, Allergology international : official journal of the Japanese Society of Allergology.

[9]  J. Piercy,et al.  Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey , 2013, Clinical and Translational Allergy.

[10]  P. Patel,et al.  Mobile Natural Exposure Chamber Technology Standardizes Controlled Environmental Exposure Chamber Challenges Across Multicenter National and International Allergy Trials , 2013 .

[11]  R. Jacobs,et al.  Validation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[12]  N. Krug,et al.  Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen season. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  E. Meltzer,et al.  The economic impact of allergic rhinitis and current guidelines for treatment. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[14]  J. Mullol,et al.  Placebo effect in clinical trials involving patients with allergic rhinitis. , 2011, Journal of investigational allergology & clinical immunology.

[15]  R. Kawata,et al.  Preliminary study of a challenge test to the patients with Japanese cedar pollinosis using an environmental exposure unit. , 2010, Auris, nasus, larynx.

[16]  G. D'Amato,et al.  Urban air pollution and climate change as environmental risk factors of respiratory allergy: an update. , 2010, Journal of investigational allergology & clinical immunology.

[17]  G. Canonica,et al.  The role of allergen challenge chambers in the evaluation of anti‐allergic medication: an international consensus paper , 2006 .